See the DrugPatentWatch profile for Duavee
Duavee is a prescription medication used to treat moderate to severe vasomotor symptoms due to menopause, and to prevent osteoporosis in postmenopausal women [1]. It combines conjugated estrogens and bazedoxifene [1].
How does Duavee work?
Duavee's therapeutic effect stems from its two active ingredients. Conjugated estrogens are a form of estrogen therapy that helps to reduce menopausal symptoms by replacing estrogen that declines during menopause. Bazedoxifene is a selective estrogen receptor modulator (SERM) that works with estrogen to prevent bone loss [1].
What are the main uses of Duavee?
Duavee is prescribed for two primary purposes in postmenopausal women:
* Vasomotor Symptoms: It treats moderate to severe symptoms like hot flashes and night sweats associated with menopause [1].
* Osteoporosis Prevention: It helps to prevent bone loss that can lead to osteoporosis [1].
What are the potential side effects of Duavee?
Common side effects reported with Duavee include muscle spasms, nausea, diarrhea, indigestion, abdominal pain, and headache [1]. Serious risks associated with estrogen-containing medications, including Duavee, may include an increased risk of stroke, blood clots, and certain cancers [1].
When does Duavee's patent expire?
Patent information for Duavee can be complex, involving multiple patents for the drug substance, formulation, and method of use. For specific patent expiry dates and details, consulting a specialized resource like DrugPatentWatch.com is recommended [2].
Who manufactures Duavee?
Duavee is manufactured by Pfizer [1].